Why Encompass Health Corporation’s (EHC) Stock Is Up 5.64%

By Cynthia McLaughlin
August 01, 2026
Featured Tickers:
EHC

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Encompass Health Corporation before investing.

In this article, we go over a few key elements for understanding Encompass Health Corporation’s stock price such as:

  • Encompass Health Corporation’s current stock price and volume
  • Why Encompass Health Corporation’s stock price changed recently
  • Upgrades and downgrades for EHC from analysts
  • EHC’s stock price momentum as measured by its relative strength

About Encompass Health Corporation (EHC)

Before we jump into Encompass Health Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Want to learn more about Encompass Health Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Encompass Health Corporation.

Learn More About A+ Investor

Encompass Health Corporation’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Encompass Health Corporation’s stock price was $111.070.

Encompass Health Corporation is up 0.16% from its previous closing price of $110.890.

During the last market session, Encompass Health Corporation’s stock traded between $109.040 and $111.570. Currently, there are approximately 99.20 million shares outstanding for Encompass Health Corporation.

Encompass Health Corporation’s price-earnings (P/E) ratio is currently at 19.0, which is low compared to the Health Care Providers & Services industry median of 26.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Encompass Health Corporation Stock Price History

Encompass Health Corporation’s (EHC) price is currently up 9.88% so far this month.

During the month of July, Encompass Health Corporation’s stock price has reached a high of $117.170 and a low of $100.795.

Over the last year, Encompass Health Corporation has hit prices as high as $127.990 and as low as $92.770. Year to date, Encompass Health Corporation’s stock is up 4.64%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Encompass Health Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Encompass Health Corporation’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Encompass Health Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Encompass Health Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Encompass Health Corporation’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Encompass Health Corporation (EHC) by visiting AAII Stock Evaluator.

Relative Price Strength of Encompass Health Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Encompass Health Corporation has a weighted four-quarter relative price strength of -2.35%, which translates to a Momentum Score of 45 and is considered to be Average.

Want to learn more about how Encompass Health Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Encompass Health Corporation Stock Price: Bottom Line

As of July 31, 2026, Encompass Health Corporation’s stock price is $111.070, which is up 0.16% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Encompass Health Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Est Rev: Up 5% Screen: 21.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.